A single pharmaceutical validation project — URS, risk assessment, IQ, OQ, PQ protocols, RTM, and summary report — routinely takes a qualified validation engineer 528 hours of writing, reviewing, and reworking. That is 13 weeks of one person's time, before a single test has been executed. In a regulated environment where documentation errors trigger 483 observations, this process is both slow and fragile.
PHARPRO DVS (Digital Validation System) applies regulated AI to this exact problem. Feed it a system description. It returns a complete, GAMP 5-compliant, 21 CFR Part 11-aligned validation package — ready for review, not from scratch.
Where 528 Hours Actually Goes
| Document | Manual Hours | DVS Time | Hours Saved |
|---|---|---|---|
| User Requirements Specification (URS) | 40 hrs | ~20 min | 39.5 hrs |
| Risk Assessment (FMEA) | 32 hrs | ~15 min | 31.7 hrs |
| IQ Protocol (Installation Qualification) | 64 hrs | ~30 min | 63.5 hrs |
| OQ Protocol (Operational Qualification) | 96 hrs | ~45 min | 95.2 hrs |
| PQ Protocol (Performance Qualification) | 80 hrs | ~40 min | 79.3 hrs |
| Requirements Traceability Matrix (RTM) | 48 hrs | ~5 min (auto-generated) | 47.9 hrs |
| Validation Summary Report | 32 hrs | ~15 min | 31.7 hrs |
| Review & QA alignment cycles | 136 hrs | ~2 hrs (focused review) | 134 hrs |
| Total | 528 hrs | ~4.5 hrs | ~523.5 hrs |
The AI is regulated, not uncontrolled. DVS does not produce generic text that fails audit. Every document it generates is cross-referenced to GAMP 5 risk categories, FDA 21 CFR Part 11 clauses, and EU GMP Annex 11 requirements. The AI operates within a controlled, auditable framework.
What DVS Generates
URS
User Requirements Specification with functional and non-functional requirements, regulatory cross-references, and risk flags.
Risk Assessment
FMEA-based risk assessment with impact, probability, and detectability scores. GAMP 5 software category determination.
IQ Protocol
Installation Qualification protocol with installation verification steps, component checks, and documented acceptance criteria.
OQ Protocol
Operational Qualification protocol with test scripts, expected results, and functional test coverage matrix.
PQ Protocol
Performance Qualification protocol with business process scenarios, performance acceptance criteria, and user acceptance testing scripts.
RTM
Requirements Traceability Matrix auto-generated from URS — every requirement linked to its test case and execution record.
Validation Summary
Validation Summary Report with executive summary, deviations, open actions, and conclusion statement ready for QA sign-off.
Audit Trail
Complete electronic audit trail for all document creation, review, approval, and change events. 21 CFR Part 11 compliant.
See it live in your use case. 30 minutes. PHARPRO DVS generates your specific system's documentation live in the demo.
Book Free Demo →What Makes DVS AI "Regulated"
The pharmaceutical industry's concern with AI is not the technology — it's the validation of the AI itself. An AI system that generates uncontrolled output creates more compliance risk than it eliminates. DVS addresses this directly:
- The AI is validated under GAMP 5 Category 4: Configured software with documented validation evidence, IQ/OQ/PQ executed on the DVS system itself
- Output is traceable: Every generated document references the regulation it satisfies and the GAMP 5 guidance it follows
- Human review is mandatory, not optional: DVS generates a review-ready draft — a qualified engineer reviews, approves, and signs via 21 CFR Part 11 electronic signature
- Change control: All document versions, approvals, and changes are recorded in an immutable audit trail
- No hallucination risk in the regulatory framework: The AI operates within a constrained regulatory template — it cannot invent requirements that don't exist
Who Should Use DVS
- Validation engineers running 3+ system validations per year — DVS eliminates the documentation bottleneck entirely
- QA teams reviewing validation packages — DVS generates consistent, reviewable documentation rather than engineer-by-engineer style variation
- Pharmaceutical manufacturers with upcoming FDA or EU GMP inspections who need validation records closed quickly
- CROs and CMOs managing validation across multiple client systems and needing scalable documentation capability
- Regulatory affairs teams preparing dossiers that include system validation summaries